Blockchain platform introduces high-speed EVM with multi-VM support
Injective’s support for EVM and Wasm is part of its broader multi-VM initiative, which aims to create a blockchain ecosystem that caters to a wide range of developers and applications. Think of it as ...
ENDPOINTS NEWS2d
Aus­tralian biotech Ad­van­Cell nabs $112M Se­ries C for ra­dio­phar­ma­ceu­ti­cals
Radiopharmaceuticals biotech AdvanCell has pulled together a $112 million Series C about two years after its much smaller ...
BBC Morning Live's Gethin Jones asks 'what do you mean?' as co-hosts tease him in hilarious moment
On Tuesday morning, the Welsh presenter was joined by his co-presenter Michelle Ackerley and Strictly star Neil Jones in an ...
On Mass Effect 2’s anniversary, what do we know about the next game?
As Mass Effect 2 celebrates its 15th anniversary, we look into why the new game is taking so long and whether it will ever be ...
Hosted on MSN13d
The Reapers' History, Explained - Mass Effect
The grandest villains of the Mass Effect trilogy have a fascinating history.
GameSpot13d
New Mass Effect Jack And Legion Collectibles Are On The Way From Dark Horse
Jack and Legion are joining Dark Horse Direct's line of highly detailed Mass Effect collectibles.
ENDPOINTS NEWS15d
With sup­port from NFL own­er Jef­frey Lurie, Ice­landic biotech clos­es Se­ries A for oral Alzheimer's drug
A father-and-son biotech with ties to Iceland and Philadelphia has put together a €26.5 million Series A to develop oral treatments for Alzheimer’s disease and other neurodegenerative conditions.